Autogenic Inhibition Versus Reciprocal Inhibition Muscle Energy Techniques in Iliotibial Band Syndrome
NCT ID: NCT06867159
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2024-07-15
2025-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Intermittent Occlusion and Static Stretching
NCT04574661
Comparison of Active and Passive Static Stretching in Delayed Onset of Muscle Soreness of Recreational Body Builders
NCT04636281
Comparasion of Autogenic Inhibition and Reciprocal Inhibition Muscle Energy Techniques (METS) in Piriformis Syndrome
NCT06460675
Comparison of Active Isolated Stretch and Post Isometric Relaxation for Hamstring Flexibility.
NCT04024839
Effects of Movement Pattern Training Versus Proprioceptive Neuromuscular Training in Footballers With Groin Pain
NCT06819384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The outcomes will be measured in terms of improvements in pain score (NPRS), hip range of motion (ROM), and overall lower extremity function.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autogenic Inhibition (AI) MET Group
Autogenic Inhibition (AI) MET (Post Facilitation Stretch)
1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
2. The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
3. On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.
Autogenic Inhibition (AI) MET (Post Facilitation Stretch)
Autogenic Inhibition (AI) MET (Post Facilitation Stretch)
1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
2. The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
3. On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.
Reciprocal Inhibition (RI) MET Group
Reciprocal Inhibition (RI) MET
1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
2. The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
3. On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.
Reciprocal Inhibition (RI) MET
Reciprocal Inhibition (RI) MET
1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
2. The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
3. On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autogenic Inhibition (AI) MET (Post Facilitation Stretch)
Autogenic Inhibition (AI) MET (Post Facilitation Stretch)
1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
2. The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
3. On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.
Reciprocal Inhibition (RI) MET
Reciprocal Inhibition (RI) MET
1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
2. The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
3. On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age : 19-45years (8)
* Lateral knee pain (\>3 months)
* Tenderness over lateral femoral condyle
* Positive Flexibility Tests
* Modified Ober's test (9)
* Length assessment of Tensor Fasciae Latae and Iliotibial Band (10)
* Positive Pain Provocation Tests
* Renne's test
* Noble's Compression test (11) \*(individuals with 3 positive tests out of above mentioned 4 tests will be included)
Exclusion Criteria
* Lower limb fractures or trauma within the past year.
* Multiple lower limb surgeries (\>2)
* Presence of any structural or postural disorders (kyphosis or severe scoliosis)
* Neurological disorders
* Hip and knee Osteoarthritis
* Rheumatoid Arthritis
* Pregnancy
19 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foundation University Islamabad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foundation University College of Physcial Therapy
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FUI/CTR/2025/3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.